We are pleased to announce that the European Journal of Microbiology and Immunology has been selected for coverage in the Emerging Sources Citation Index (ESCI)
At the same time the journal is under evaluation by Clarivate Analytics to be accepted in the Science Citation Index Expanded(TM).
European Journal of Microbiology and Immunology is a Gold Open Access journal. It reports new discoveries in the field of medical microbiology and immunology of infection. Major focus on infections caused by pathogenic bacteria and parasites; molecular mechanisms of pathogenicity; host pathogen interaction; innate and adaptive immunity to infection and antimicrobial chemotherapy.
Topics that will be published are as follows: Reviews, original articles, results of prospective randomized trials, case studies, and PhD-theses summaries
Papers submitted are subject to single blind peer review performed by two independent reviewers. Papers accepted for publication by the Editorial Board are subject to editorial revision.
Articles are deposited on PubMedCentral following publication of an issue on the journal's official website.
Live biotherapeutic products are progressing through the clinic with purpose, but as microbiome targeting therapeutics move closer to commercialization, key regulatory, manufacturing and supply chain challenges become apparent. At Microbiome Connect: Gut Therapeutics EU, you will find solutions to these challenges and more.
For our readers, we have secured a 10% discount to Microbiome Connect: Gut Therapeutics USA. Use the code AKJ10 for 10% off your ticket.
The author instruction is available in PDF. Please, download the file from HERE.